![Clifford L. Hendrick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Clifford L. Hendrick
Amministratore Delegato presso Cetya Therapeutics, Inc.
Profilo
Clifford L.
Hendrick is currently the Chief Executive Officer and Director at Cetya Therapeutics, Inc.
Posizioni attive di Clifford L. Hendrick
Società | Posizione | Inizio |
---|---|---|
Cetya Therapeutics, Inc.
![]() Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Cetya Therapeutics, Inc.
![]() Cetya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cetya Therapeutics, Inc. engages in the commercialization of histone deacetylase inhibitors based on largazole. Its histone deacetylase inhibitors analog has bifunctional modifications and the potential to target specific cell types or tumors. The company was founded by John Pilon in 2012 and is headquartered in Fort Collins, Co. | Health Technology |
- Borsa valori
- Insiders
- Clifford L. Hendrick